Why Cancer Drug Spending Spiked Last Year

A study finds that novel and pricey new therapies led to a sharp spike in global cancer drug spending last year.

The worldwide oncology drug market ballooned to $107 billion in 2015, according to the report by IMS Health, with spending on cancer treatments swelling 11.5%. The market is expected to reach $150 billion by 2020.

Read Full Article »
Comment
Show commentsHide Comments

Related Articles